Login
$IONS
$28.02 +$0.01 (0.04%) After hours

Insider Transactions

What IONIS PHARMACEUTICALS INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 1 3
Sells 2 106
Total trades 9 215

Shares traded

3 months 12 months
Acquired 8,274 1,558,657
Disposed 1,410 1,472,177
Net activity +6,864 +86,480

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Hayden Michael R Director Nov 10 Open-market buy · P +5,000 $29.64 +$148K 27,000
Swayze Eric EVP Research Oct 16 Sale for tax withholding · S −53 $43.54 −$2.31K 390
Devers Shannon L. EVP, Chief Human Resources Ofc Oct 16 Sale for tax withholding · S −1,357 $43.54 −$59.1K 17,811
Swayze Eric EVP Research Oct 15 Exercise / conversion · M +125 — — 443
Devers Shannon L. EVP, Chief Human Resources Ofc Oct 15 Exercise / conversion · M +2,820 — — 19,168
Birchler Brian EVP, Corp and Development Ops Aug 31 Other Transaction · J +58 $51.31 +$2.98K 102,883
O'neil Patrick R. EVP CLO & General Counsel Aug 31 Other Transaction · J +63 $51.31 +$3.23K 59,205
Monia Brett P Chief Executive Officer Aug 31 Other Transaction · J +98 $51.31 +$5.03K 242,760
Bennett C Frank EVP, Chief Scientific Officer Aug 31 Other Transaction · J +110 $51.31 +$5.64K 60,128
Hayden Michael R Director Jul 31 Open-market buy · P +5,000 $51.60 +$258K 24,000
Hayden Michael R Director Jul 30 Open-market buy · P +15,000 $53.38 +$801K 19,000
Berthelsen Spencer R Director Jul 15 Exercise / conversion · M +5,220 — — 161,233
Herman Joan E Director Jul 15 Exercise / conversion · M +5,220 — — 51,306
Diaz Allene M. Director Jul 07 Disclosed 10b5-1 sale · S −10,111 $85.42 −$864K 3,811
Diaz Allene M. Director Jul 07 Exercise / conversion · M +10,111 $47.11 +$476K 13,922
Bennett C Frank EVP, Chief Scientific Officer Jul 07 Disclosed 10b5-1 sale · S −15,000 $85.46 −$1.28M 0
Bennett C Frank EVP, Chief Scientific Officer Jul 07 Other Transaction · J +15,000 — — 15,000
Bennett C Frank EVP, Chief Scientific Officer Jul 07 Disclosed 10b5-1 sale · S −5,536 $83.58 −$463K 75,018
Kordasiewicz Holly B. EVP, Chief Development Officer Jul 07 Disclosed 10b5-1 sale · S −362 $84.30 −$30.5K 22,096
Klein Joseph Iii Director Jul 01 Disclosed 10b5-1 sale · S −11,419 $79.04 −$903K 11,014

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support